Skip to Main Content
Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is encouraging. We plan to curl up with a couple of library books, hang with our shortest person, and promenade with our official mascot, who is a lucky boy because he has a two-week sleepover with a neighborhood playmate. Of course, this will make for a busy Pharmalot campus. Wish us luck. And what about you? A holiday is beckoning for many, so time to shop before prices rise even further, assuming you can find anything. You could contribute to the greater good and convince some folks to get vaccinated. Or simply plan the future, since that is where you can expect to spend much of your time. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

Amid the national furor over abortion, the Food and Drug Administration permanently removed a controversial restriction on access to abortion pills by allowing patients to receive the medicine by mail, instead of requiring them to get the pills in person from specially certified providers, STAT explains. The decision means that medication abortion may become more widely available to women who find it difficult to travel to abortion providers. Going forward, any doctor who is certified to prescribe the pill, which is known as mifepristone, can do so online and have it sent by mail, which will allow pregnancies to be terminated at home, even if the U.S. Supreme Court strikes down Roe v. Wade.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment